|Security||INNV / Innovus Pharmaceuticals, Inc. (45778V106)|
|PRESIDENT AND CEO||Damaj Bassam|
|Institutional Shares||25,617,592 - 15.58%|
|Common Shares Outstanding||164,434,088 shares (as of 2017-09-30)|
Institutional Stock Ownership and Shareholders
Innovus Pharmaceuticals, Inc. (OTC:INNV) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25,617,592 shares. Largest shareholders include Novalere Holdings, LLC.
Innovus Pharmaceuticals, Inc. (OTC:INNV) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
Stop missing out on important events!
|File Date||Form||Investor||Opt||Prev Shares||Current Shares||Change
|Prev Value (x$1000)||Current Value (x$1000)||Change|
|Novalere Holdings, LLC||25,617,592||25,617,592||0.00|